Q2i provides technology for healthcare teams treating Opioid Use Disorder (OUD) and Substance Use Disorder. Q2i's products, which include a healthcare team portal and patient mobile app, facilitate improvements in patient care by supporting patients with their treatment plans through better connection and information exchange with their healthcare teams. In addition, the firm's products incorporate market-leading artificial intelligence and machine learning that enable providers to predict risk of relapse and flag trending issues and areas of concern, resulting in more timely interventions and improved outcomes. Q2i's telehealth capabilities allow healthcare teams to care for OUD patients remotely, making treatment more accessible for OUD patients in remote areas.
